SEARCH

SEARCH BY CITATION

References

  • 1
    Mechoulam R,Ben-Shabat S,Hanus L,Ligumsky M,Kaminski NE,Schatz AR,Gopher A,Almog S,Martin BR,Compton DR,Pertwee RG,Griffin G, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 8390.
  • 2
    Sugiura T,Kondo S,Sukagawa A,Nakane S,Shinoda A,Itoh K,Yamashita A,Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 8997.
  • 3
    Nithipatikom K,Endsley MP,Isbell MA,Falck JR,Iwamoto Y,Hillard CJ,Campbell WB. 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res 2004; 64: 882630.
  • 4
    Nithipatikom K,Endsley MP,Isbell MA,Wheelock CE,Hammock BD,Campbell WB. A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. Biochem Biophys Res Commun 2005; 332: 102833.
  • 5
    Endsley MP,Aggarwal N,Isbell MA,Wheelock CE,Hammock BD,Falck JR,Campbell WB,Nithipatikom K. Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: location, hydrolysis and 12-lipoxygenase metabolism. Int J Cancer 2007; 121: 98491.
  • 6
    Nie D,Nemeth J,Qiao Y,Zacharek A,Li L,Hanna K,Tang K,Hillman GG,Cher ML,Grignon DJ,Honn KV. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis 2003; 20: 65763.
  • 7
    Liu B,Maher RJ,De Jonckheere JP,Popat RU,Stojakovic S,Hannun YA,Porter AT,Honn KV. 12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC α. Adv Exp Med Biol 1997; 400B: 70718.
  • 8
    Hughes-Fulford M,Chen Y,Tjandrawinata RR. Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis 2001; 22: 7017.
  • 9
    Goparaju SK,Ueda N,Yamaguchi H,Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 1998; 422: 6973.
  • 10
    Dinh TP,Freund TF,Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids 2002; 121: 14958.
  • 11
    Bisogno T,Howell F,Williams G,Minassi A,Cascio MG,Ligresti A,Matias I,Schiano-Moriello A,Paul P,Williams EJ,Gangadharan U,Hobbs C, et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 2003; 163: 4638.
  • 12
    Di Marzo V,Bisogno T,Sugiura T,Melck D,De Petrocellis L. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem J 1998; 331(Part 1): 1519.
  • 13
    Balsinde J,Diez E,Mollinedo F. Arachidonic acid release from diacylglycerol in human neutrophils. Translocation of diacylglycerol-deacylating enzyme activities from an intracellular pool to plasma membrane upon cell activation. J Biol Chem 1991; 266: 1563843.
  • 14
    Di Marzo V,Bisogno T,De Petrocellis L,Melck D,Orlando P,Wagner JA,Kunos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 1999; 264: 25867.
  • 15
    Ho WS,Hillard CJ. Modulators of endocannabinoid enzymic hydrolysis and membrane transport. Handb Exp Pharmacol 2005; 168: 187207.
  • 16
    Schmid PC,Zuzarte-Augustin ML,Schmid HH. Properties of rat liver N-acylethanolamine amidohydrolase. J Biol Chem 1985; 260: 141459.
  • 17
    Desarnaud F,Cadas H,Piomelli D. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 1995; 270: 60305.
  • 18
    Hillard CJ,Wilkison DM,Edgemond WS,Campbell WB. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim Biophys Acta 1995; 1257: 24956.
  • 19
    Ueda N,Kurahashi Y,Yamamoto S,Tokunaga T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem 1995; 270: 238237.
  • 20
    Cravatt BF,Giang DK,Mayfield SP,Boger DL,Lerner RA,Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996; 384: 837.
  • 21
    Ruiz-Llorente L,Ortega-Gutierrez S,Viso A,Sanchez MG,Sanchez AM,Fernandez C,Ramos JA,Hillard C,Lasuncion MA,Lopez-Rodriguez ML,Diaz-Laviada I. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. Br J Pharmacol 2004; 141: 45767.
  • 22
    Nithipatikom K,Isbell MA,Lindholm PF,Kajdacsy-Balla A,Kaul S,Campell WB. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis 2002; 19: 593601.
  • 23
    Mimeault M,Pommery N,Wattez N,Bailly C,Henichart JP. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate 2003; 56: 112.
  • 24
    De Petrocellis L,Starowicz K,Moriello AS,Vivese M,Orlando P,Di Marzo V. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. Exp Cell Res 2007; 313: 191120.
  • 25
    Thebault S,Lemonnier L,Bidaux G,Flourakis M,Bavencoffe A,Gordienko D,Roudbaraki M,Delcourt P,Panchin Y,Shuba Y,Skryma R,Prevarskaya N. Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells. J Biol Chem 2005; 280: 3942335.
  • 26
    Dhanasekaran SM,Dash A,Yu J,Maine IP,Laxman B,Tomlins SA,Creighton CJ,Menon A,Rubin MA,Chinnaiyan AM. Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty. FASEB J 2005; 19: 2435.
  • 27
    Saario SM,Salo OM,Nevalainen T,Poso A,Laitinen JT,Jarvinen T,Niemi R. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem Biol 2005; 12: 64956.
  • 28
    Saario SM,Savinainen JR,Laitinen JT,Jarvinen T,Niemi R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 2004; 67: 13817.
  • 29
    Muccioli GG,Xu C,Odah E,Cudaback E,Cisneros JA,Lambert DM,Lopez Rodriguez ML,Bajjalieh S,Stella N. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 2007; 27: 28839.
  • 30
    Grimaldi C,Pisanti S,Laezza C,Malfitano AM,Santoro A,Vitale M,Caruso MG,Notarnicola M,Iacuzzo I,Portella G,Di Marzo V,Bifulco M. Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res 2006; 312: 36373.
  • 31
    Ramer R,Hinz B. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 2008; 100: 5969.
  • 32
    Dahiya R,Boyle B,Goldberg BC,Yoon WH,Konety B,Chen K,Yen TS,Blumenfeld W,Narayan P. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem Cell Biol 1992; 70: 54854.
  • 33
    Brown MD,Hart CA,Gazi E,Bagley S,Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer 2006; 94: 84253.
  • 34
    Ghosh J,Myers CE. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997; 235: 41823.
  • 35
    Izzo AA,Aviello G,Petrosino S,Orlando P,Marsicano G,Lutz B,Borrelli F,Capasso R,Nigam S,Capasso F,Di Marzo V. Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med 2007; 86: 8998.